Involvement of hypothalamic peptides in the anorectic action of the CB 1 receptor antagonist rimonabant (SR 141716)

European Journal of Neuroscience

Volumn 29, Issue 11, 2009, Pages 2207-2216

  Verty, Aaron N A ^a   Boon, Wee M ^a   Mallet, Paul E ^b   McGregor, Iain S ^c   Oldfield, Brian J ^a  

^a MONASH UNIVERSITY   (Australia)

^b WILFRID LAURIER UNIVERSITY   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Appetite; C fos; Endocannabinoid; Hypothalamus; Peptides; Rimonabant

Indexed keywords

ALPHA INTERMEDIN; BRAIN PEPTIDE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; MELANIN CONCENTRATING HORMONE; MESSENGER RNA; OREXIN; PROTEIN FOS; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN REGION; CELL ACTIVATION; CELL NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG MECHANISM; ENERGY EXPENDITURE; FEEDING; FOOD INTAKE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; THALAMUS MIDLINE NUCLEUS; WESTERN BLOTTING;

ANIMALS; APPETITE DEPRESSANTS; FOOD DEPRIVATION; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; MALE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID;

EID: 66449135959     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.06750.x     Document Type: Article

References (52)

1. Ameri, A. (1999) The effects of cannabinoids on the brain. Prog. Neurobiol., 58, 315 348. (Pubitemid 29230000)
2. 1) receptors. Psychopharmacology, 132, 104 106.
3. Backberg, M., Hervieu, G., Wilson, S. Meister, B. (2002) Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur. J. Neurosci., 15, 315 328. (Pubitemid 35471953)
4. Bi, S., Robinson, B.M. Moran, T.H. (2003) Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression. Am. J. Physiol. Regul. Integr. Comp. Physiol., 285, R1030 1036.
5. Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R. Gessa, G.L. (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR141716. Life Sci., 63, PL113 PL117.
6. Cota, D., Marsicano, G., Tschop, M., Grubler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thone-Reineke, C., Ortmann, S., Tomassoni, F., Cervino, C., Nisoli, E., Linthorst, A.C., Pasquali, R., Lutz, B., Stalla, G.K. Pagotto, U. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest., 112, 423 431. (Pubitemid 38063771)
7. Crespo, I., Gómez de Heras, R., Rodríguez de Fonseca, F. Navarro, M. (2008) Pretreatment with subeffective doses of rimonabant attenuates orexigenic actions of orexin A-hypocretin 1. Neuropharmacology, 54, 219 225.
8. Dallman, M.F., Akana, S.F., Bhatnagar, S., Bell, M.E., Choi, S., Chu, A., Horsley, C., Levin, N., Meijer, O., Soriano, L.R., Strack, A.M. Viau, V. (1999) Starvation: early signals, sensors, and sequelae. Endocrinology, 140, 4015 4023. (Pubitemid 30647096)
9. Despres, J.P., Golay, A. Sjostrom, L. (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med., 353, 2121 2134. (Pubitemid 41653104)
10. Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T. Kunos, G. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature, 410, 822 825. (Pubitemid 32303781)
11. Elias, C.F., Lee, C., Kelly, J., Aschkenasi, C., Ahima, R.S., Couceyro, P.R., Kuhar, M.J., Saper, C.B. Elmquist, J.K. (1998) Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron, 21, 1375 1385. (Pubitemid 29022539)
12. Gamber, K.M., Macarthur, H. Westfall, T.C. (2005) Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology, 49, 646 652. (Pubitemid 41208286)
13. Greenberg, M.E., Ziff, E.B. Greene, L.A. (1986) Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science, 234, 80 83. (Pubitemid 17171550)
14. Harris, G.C., Wimmer, M. Aston-Jones, G. (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature, 437, 556 559. (Pubitemid 41613553)
15. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. Rice, K.C. (1991) Characterization and localization of cannabiniod receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563 583.
16. Huang, H., Acuna-Goycolea, C., Li, Y., Cheng, H.M., Obrietan, K. van den Pol, A.N. (2007) Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal. J. Neurosci., 27, 4870 4871.
17. Jamshidi, N. Taylor, D.A. (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol., 134, 1151 1154. (Pubitemid 33097243)
18. Kirkham, T.C., Williams, C.M., Fezza, F. Di Marzo, V. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol., 136, 550 557. (Pubitemid 34717699)
19. Kola, B., Farkas, I., Christ-Crain, M.W.G., Lolli, F., Amin, F., Harvey-White, J., Liposits, Z., Kunos, G., Grossman, A.B., Fekete, C. Korbonits, M. (2008) The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE, 3, e1797.
20. Kowalski, T.J., Spar, B.D., Weig, B., Farley, C., Cook, J., Ghibaudi, L., Fried, S., O'Neill, K., Del Vecchio, R.A., McBriar, M., Guzik, H., Clader, J., Hawes, B.E. Hwa, J. (2006) Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice. Eur. J. Pharmacol., 535, 182 191.
21. Lambert, P.D., Phillips, P.J., Wilding, J.P., Bloom, S.R. Herbert, J. (1995) c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y. Brain Res., 670, 59 65.
22. Livak, K.J. Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402 408. (Pubitemid 34164012)
23. Matias, I., Bisogno, T. Di Marzo, V. (2006) Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int. J. Obes. (Lond), 30 (Suppl. 1 S7 S12.
24. McMinn, J.E., Wilkinson, C.W., Havel, P.J., Woods, S.C. Schwartz, M.W. (2000) Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, R695 R703.
25. Mechoulam, R., Fride, E. Di Marzo, V. (1998) Endocannabinoids. Eur. J. Pharmacol., 359, 1 18. (Pubitemid 28515716)
26. Osei-Hyiaman, D., Depetrillo, M., Harvey-White, J., Bannon, A.W., Cravatt, B.F., Kuhar, M.J., Mackie, K., Palkovits, M. Kunos, G. (2005) Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology, 81, 273 282. (Pubitemid 41397036)
27. Osei-Hyiaman, D., Harvey-White, J. Bátkai, S.K.G. (2006) The role of the endocannabinoid system in the control of energy homeostasis. Int. J. Obes. (Lond), 30 (Suppl. 1 S33 S38.
28. Padwal, R.S. Majumdar, S.R. (2007) Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet, 369, 71 77. (Pubitemid 46027230)
29. 1 receptor deleted mice. Neurosci. Lett., 343, 216 218. (Pubitemid 38365988)
30. 1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol., 284, R345 R353.
31. Reyes, B.A.S., Yamada, S., Estacio, M.A., Maeda, K. Tsukamura, H. (2001) Effect of fasting on c-Fos expression in the hypothalamic nuclei and Nucleus of the solitary tract in male rats: time course study and the role of testosterone. J. Reprod. Dev., 47, 53 62. (Pubitemid 33259097)
32. Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., Ferrara, P., Soubrié, P., Brelière, J.C. Le Fur, G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240 244. (Pubitemid 24268029)
33. 1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. Physiol. Behav., 24, 383 388. (Pubitemid 47016540)
34. 1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci., 58, PL103 110.
35. Segal-Lieberman, G., Bradley, R.L., Kokkotou, E., Carlson, M., Trombly, D.J., Wang, X., Bates, S., Myers, M.G.J., Flier, J.S. Maratos-Flier, E. (2003) Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc. Natl Acad. Sci. USA, 100, 10085 10090. (Pubitemid 37087071)
36. Sharp, F.R., Sagar, S.M., Hicks, K., Lowenstein, D. Hisanaga, K. (1991) c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress. J. Neurosci., 11, 2321 2331.
37. Shimokawa, T., Kumar, M.V. Lane, M.D. (2002) Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proc. Natl Acad. Sci. USA, 99, 66 71. (Pubitemid 34060317)
38. Singh, M.E., Verty, A.N.A., McGregor, I.S. Mallet, P.E. (2004a) A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Res., 1026, 244 253. (Pubitemid 39361553)
39. Singh, M.E., Verty, A.N.A., Price, I., McGregor, I.S. Mallet, P.E. (2004b) Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology, 47, 1157 1169. (Pubitemid 39572707)
40. Verty, A.N.A., Singh, M.E., McGregor, I.S. Mallet, P.E. (2003) The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology, 168, 314 323. (Pubitemid 36920915)
41. 1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology, 145, 3224 3231. (Pubitemid 38829994)
42. Verty, A.N.A., McGregor, I.S. Mallet, P.E. (2004b) Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci. Lett., 354, 217 220. (Pubitemid 38045348)
43. 9-tetrahydrocannabinol. Neuropharmacology, 49, 1101 1109. (Pubitemid 41608634)
44. Verty, A.N.A., Allen, A.M. Oldfield, B.J. (2009) The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. Obesity (Silver Spring), 17, 16 24.
45. Vrang, N., Larsen, P.J., Clausen, J.T. Kristensen, P. (1999a) Neurochemical characterization of hypothalamic cocaine- amphetamine-regulated transcript neurons. J. Neurosci., 19, RC5 1.
46. Vrang, N., Tang-Christensen, M., Larsen, P.J. Kristensen, P. (1999b) Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res., 818, 499 509. (Pubitemid 29229965)
47. 1) receptors. Psychopharmacology, 143, 315 317. (Pubitemid 29204987)
48. 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol. Biochem. Behav., 71, 341 348. (Pubitemid 34102497)
49. 9-THC. Physiol. Behav., 65, 343 346. (Pubitemid 28548657)
50. Williams, G., Bing, C., Cai, X.J., Harrold, J.A., King, P.J. Liu, X.H. (2001) The hypothalamus and the control of energy homeostasis: different circuits and different purposes. Physiol. Behav., 74, 683 701. (Pubitemid 34076616)
51. Wilson, R.I. Nicoll, R.A. (2002) Endocannabinoid signaling in the brain. Science, 296, 678 682.
52. Wu, M.-F., John, J., Maidment, N., Lam, H.A. Seigel, J.M. (2003) Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am. J. Physiol. Regul. Integr. Comp. Physiol., 283, R1079 R1086.